Apexian Pharmaceuticals is Drug Discovery in United States that focus on related macular degeneration business. Founded in 2008. They cover business area such as operator, novel compound, various disease, development, commercialization, pharmaceutical, bladder cancer, pancreatic cancer, sarcoma, age-relate macular degeneration, diabetic retinopathy, inflammatory bowel disease, physician, their patient.
2008
( 16 years old in 2024 )
Related Macular Degeneration
-
20 North Meridian
Suite 801
Indianapolis, IN 46204
United States
Private
operatornovel compoundvarious diseasedevelopmentcommercializationpharmaceuticalbladder cancerpancreatic cancersarcomaage-relate macular degenerationdiabetic retinopathyinflammatory bowel diseasephysiciantheir patient
* We use standard office opening hours in near Apexian Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Apexian Pharmaceuticals is Drug Discovery business from United States that founded in 2008 (16 years old in 2024), Apexian Pharmaceuticals business is focusing on Related Macular Degeneration.
Apexian Pharmaceuticals headquarter office and corporate office address is located in 20 North Meridian Suite 801 Indianapolis, IN 46204 United States.
Apexian Pharmaceuticals was founded in United States.
In 2024, Apexian Pharmaceuticals is currently focus on related macular degeneration sector.
Above is snippet of Google Trends for "related macular degeneration" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Apexian Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
